Amino Health vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 53)
Amino Health logo

Amino Health

ChallengerHealthcare

Healthcare Navigation & Provider Search Platform

Amino Health provides a data-driven healthcare navigation platform that helps employees find high-quality, in-network providers using a 26B+ claims database; raised $70M+ total;

AI VisibilityBeta
Overall Score
C53
Category Rank
#233 of 596
AI Consensus
82%
Trend
stable
Per Platform
ChatGPT
58
Perplexity
53
Gemini
55

About

Amino Health is a digital health company founded in 2013 and headquartered in San Francisco, California, that helps employees and health plan members find high-quality, cost-effective in-network healthcare providers using data-driven recommendations. The platform is powered by a proprietary database of more than 26 billion de-identified medical claims, which enables Amino to estimate physician quality, specialty expertise, and patient cost outcomes based on actual historical treatment data rather than self-reported information or generic star ratings.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

53
Overall Score
90
#233
Category Rank
#2
82
AI Consensus
83
stable
Trend
stable
58
ChatGPT
92
53
Perplexity
93
55
Gemini
89
51
Claude
96
51
Grok
95

Key Details

Category
Healthcare Navigation & Provider Search Platform
Enterprise
Tier
Challenger
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.